AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Prescient therapeutics limited asx ptx
Get Acquainted with Prescient Therapeutics’ Next Generation Immunotherapy Platform
June 19, 2020 11:39 AM AEST| By Team Kalkine MediaPrescient Therapeutics Limited (ASX:PTX) is a clinical-stage oncology company developing personalised medicine approaches to cancer, including cellular as well as targeted therapies. The targeted therapies include two drug candidates, PTX-200 and P.....
Another Golden Feather in Prescient’s Hat, PTX-200 Receives Two US Patents
June 17, 2020 05:11 PM AEST| By Team Kalkine MediaWell-known for developing breakthrough targeted and personalised medicines approaches to treat cancer, Prescient Therapeutics Limited (ASX:PTX) has been gaining attention on the back of its recent achievements. Building on this momentum, on 17 June.....
Prescient Onboards Former Juno Executive Dr Allen Ebens, Stock Zooms Up 25%
June 04, 2020 12:22 PM AEST| By Team Kalkine MediaSummary Dr Allen Ebens was formerly a key executive in Juno Therapeutics, a CAR-T pioneer company. His experience and expertise would be valuable for PTX in developing cancer therapy platform. Vast experience of over 24 years in drug developmen.....
Impressive! Prescient Obtains Key Licenses for Next Generation Immunotherapy Platform
May 28, 2020 11:45 AM AEST| By Team Kalkine MediaSummary Prescient obtains two key licenses from world immunotherapy leader, University of Pennsylvania and Oxford University to create a revolutionary cancer therapy platform called “OmniCAR”. OmniCAR platform would allow extraordin.....
Prescient Now the Outright Owner of IP Resulting from CAR-T Collaboration
May 11, 2020 06:02 PM AEST| By Team Kalkine MediaASX-listed Australia based clinical-stage oncology player Prescient Therapeutics Limited (ASX:PTX) is engaged in the development of new drugs that demonstrate significant promise as potential innovative therapies for the treatment of challenging canc...
Prescient’s Clinical Trials for PTX100 Progressing Well; Moves to Next Stage
April 23, 2020 12:43 PM AEST| By Team Kalkine MediaClinical trials are being shuttered in increasing numbers in Australia because of the challenges posed by COVID-19; however, one clinical-stage oncology company Prescient Therapeutics Limited (ASX:PTX) continues to march ahead. The Company has a str...
Prescient Therapeutics’ Operations Remain Unscathed by COVID-19 Pandemic
April 08, 2020 12:57 PM AEST| By Team Kalkine MediaThe Coronavirus has become a health threat across the globe and as per World Health Organization (WHO) until now this pandemic has resulted in over 72,744 deaths and infected more than 1,282,931 worldwide in just a few months (8 April 2020, 1:57 GMT,...
Prescient Therapeutics- A Shining Star Amidst Cancer Space
March 27, 2020 01:58 PM AEDT| By Team Kalkine Media1 in 6 deaths is due to cancer As per World Health Organization, Cancer is the 2nd major cause of death globally, and is responsible for an ~9.6 million deaths in 2018. Worldwide, about one in six deaths is owing to cancer. Demand for effective can...
Prescient Therapeutics Update on Half Year Financials: Positive Clinical Development Continued
March 02, 2020 12:33 PM AEDT| By Team Kalkine MediaPrescient Therapeutics Limited (ASX: PTX) is an Australian based clinical-stage oncology company which is into small molecule drug development focused on new drugs for the treatment of a range of cancers that have become resistant to front line chemo...
Mapping Prescient’s PTX-200 Progress
February 19, 2020 02:14 PM AEDT| By Team Kalkine MediaKnown for developing breakthrough personalised medicines using an approach to address specific mutations that drive cancer, thereby providing resistance to front line chemotherapy, Prescient Therapeutics Limited (ASX: PTX) has been gaining...
Prescient’s “BASKET” Approach Transforming Future Clinical Trials
January 30, 2020 06:54 PM AEDT| By Team Kalkine MediaClinical-stage oncology company, headquartered in Melbourne, Australia, Prescient Therapeutics (ASX:PTX) (“Prescient”), develops personalised medicines to defeat cancer taking an approach to address mutations that cause cancer. Current &...
Advertise your brand on Kalkine Media